SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Milionis, H. J
Right arrow Articles by Siamopoulos, K. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milionis, H. J
Right arrow Articles by Siamopoulos, K. C
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome

Haralampos J Milionis

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece, hmilioni{at}cc.uoi.gr

Michael S Kostapanos

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Konstantinos Vakalis

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Ioanna Theodorou

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Ioanna Bouba

Laboratory of Human Reproductive Genetics, School of Medicine, University of Ioannina, Ioannina, Greece

Rigas Kalaitzidis

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Ioannis Georgiou

Laboratory of Human Reproductive Genetics, School of Medicine, University of Ioannina, Ioannina, Greece

Moses S Elisaf

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Kostas C Siamopoulos

Department of Internal Medicine, Outpatient Hypertension Clinic, School of Medicine, University of Ioannina, Ioannina, Greece

Objective. To evaluate the influence of clinical, biochemical and genetic markers on the response to antihypertensive treatment in patients with essential hypertension and the metabolic syndrome (MetS).

Methods. Measurements of anthropometric indices, blood pressure (BP), and metabolic parameters were obtained from the medical records of 132 (77 women) newly diagnosed, untreated hypertensive patients. Renin-angiotensin-aldosterone system (RAAS) genes polymorphisms (including ACE I/D, angiotensinogen M235T, angiotensin II type 1 receptor [AT1-receptor] A1166C) were determined. Response to treatment was defined as BP less than 140/90 mmHg.

Results. Patients with MetS (n=60) had higher systolic BP and pulse pressure and a more atherogenic lipid profile than patients without MetS.The frequencies of the ACE and the AT1-receptor gene polymorphisms were similar between patients with and without MetS. Response to treatment was positively associated with pulse pressure, and the presence of the C allele as well as the AC genotype of the AT1-receptor gene and inversely with age after adjustment for confounding factors.

Conclusions. RAAS genes distribution does not differ between hypertensive patients with and without the MetS. Higher baseline pulse pressure levels, the presence of the C allele and/or the AC genotype may be in favour of a better response to structured antihypertensive treatment in patients with MetS. However, these findings need to be evaluated in future studies.

Key Words: essential hypertension • metabolic syndrome • renin-angiotensin-aldosterone system genes • response to treatment

References

  • Malik S., Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.[Abstract/Free Full Text]
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.[Free Full Text]
  • Gazi I., Liberopoulos E., Mikhailidis DP, Elisaf M. Metabolic syndrome: clinical features leading to therapeutic strategies. Vasc Dis Prev 2004;1:243-53.[CrossRef]
  • Eckel RH, Grundy SM, Zimmet PZ The metabolic syndrome. Lancet 2005;365:1415-28.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Grundy SM, Cleeman JI, Daniels SR et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.[Free Full Text]
  • Alberti KG, Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome a new worldwide definition. Lancet 2005;366:1059-62. 2005;46:258-62.[CrossRef]
  • Liberopoulos E., Elisaf M. Diagnosis of the metabolic syndrome: which definition should we use? Hell J Cardiol
  • Barnett AH, Bain SC, Bouter P. et al. Diabetics exposed to telmisartan and enalapril Study Group. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004;351:1952-61.[Abstract/Free Full Text]
  • Scheen AJ Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 2004;64:2537-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Strazzullo P., Galletti F. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism. Curr Opin Nephrol Hypertens 2004;13:325-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sharma AM Is there a rationale for angiotensin blockade in the management of obesity hypertension? Hypertension 2004;44:12-19.[Abstract/Free Full Text]
  • Li X., Du Y., Du Y., Huang X. Correlation of angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol Ther 2003;8:25-30.[Abstract/Free Full Text]
  • Dieguez-Lucena JL, Aranda-Lara P., Ruiz-Galdon M., Garcia-Villanova J., Morell-Ocana M., Reyes-Engel A. Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy. Hypertension 1996;28:98-103.[Abstract/Free Full Text]
  • Mondorf UF, Russ A., Wiesemann A., Herrero M., Oremek G., Lenz T. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens 1998;11:174-83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kurland L., Melhus H., Karlsson J. et al. Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. J Hypertens 2001;19:1783-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Baudin B. Angiotensin I-converting enzyme gene polymorphism and drug response. Clin Chem Lab Med 2000; 38:853-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
  • Milionis HJ, Papakostas J., Kakafika A., Chasiotis G., Seferiadis K., Elisaf MS Comparative effects of atorvastatin, simvastatin and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol 2003; 43:825-30.[Abstract/Free Full Text]
  • Cockroft DW, Gault MH Prediction of creatinine clearance form serum creatinine. Nephron 1976;16:31-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Russ AP, Maerz W., Ruzicka V., Stein U., Gross W. Rapid detection of hypertension-associated Met235 - Thr allele of the human angiotensinogen gene. Hum Mol Gen 1993;2:609-10.[Free Full Text]
  • Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme levels. J Clin Invest 1990; 86:1343-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9.[Abstract/Free Full Text]
  • Engeli S., Negrel R., Sharma AM Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000;35:1270-7.[Abstract/Free Full Text]
  • Massiera F., Seydoux J., Geloen A. et al. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001;142:5220-5.[Abstract/Free Full Text]
  • Goossens GH, Blaak EE, van Baak MA Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003;4:43-55.[CrossRef][Medline] [Order article via Infotrieve]
  • Nickenig G., Roling J., Strehlow K., Schnabel P., Bohm M. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998;98:2453-60.[Abstract/Free Full Text]
  • Nakai K., Itoh C., Miura Y. et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.[Abstract/Free Full Text]
  • Lachurie ML, Azizi M., Guyene TT, Alhenc-Gelas F., Menard J. Angiotensin converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-42.[Abstract/Free Full Text]
  • Castellano M., Muiesan ML, Rizzoni D. et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995;91:2721-4.[Abstract/Free Full Text]
  • Paillard F., Chansel D., Brand E. et al. Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population. Hypertension 1999;34:423-9.[Abstract/Free Full Text]
  • Thomas GN, Tomlinson B., Chan JC, Sanderson JE, Cockram CS, Critchley JA Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 2001;24:356-61.[Abstract/Free Full Text]
  • Katsuya T., Horiuchi M., Chen YDI et al. Relation between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia and dislipidemia. Arterioscler Thromb Vasc Biol 1995;15:779-82.[Abstract/Free Full Text]
  • Chiu KC, McCarthy JE The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 1997;46:395-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Panahloo A., Andres C., Mohamed-Ali V. et al. The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Circulation 1995;92:3390-3.[Abstract/Free Full Text]
  • Williams RR, Hunt SC, Hopkins PN et al. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 1993;6:319S-327S.[Medline] [Order article via Infotrieve]
  • Nagi DK, Foy CA, Mohamed-Ali V., Yudkin JS, Grant PJ, Knowler WC Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indian. Metabolism 1998;47:622-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • del Ser T., Bornstein B., Barba R., Cemillan C. Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients. Neurosci Lett 2001;316:21-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lee YJ, Tsai JC ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002;25:1002-08.[Abstract/Free Full Text]
  • Frazier L., Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic. Pharmacogenom J 2004;4:17-23.[CrossRef]
  • Benetos A., Gautier S., Ricard S. et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996;94:698-703.[Abstract/Free Full Text]
  • Castellano M., Muiesan ML, Beschi M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure. Hypertension 1996;28:1076-80.[Abstract/Free Full Text]
  • Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-9.[Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 4, 181-189 (2007)
DOI: 10.3317/jraas.2007.027


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Milionis, H. J
Right arrow Articles by Siamopoulos, K. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milionis, H. J
Right arrow Articles by Siamopoulos, K. C
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement